Form 4: CME Group Executive Jack J. Tobin Reports Stock Transactions

Jack J. Tobin, MD Chief Accounting Officer of CME Group Inc., reports the acquisition and disposal of company stock on September 15 and 16, 2024.

Summary

• On September 15, 2024, Jack J. Tobin surrendered 252 shares of CME Group Class A common stock at a price of $216.99 to cover tax obligations related to vesting restricted stock.
• Following this transaction, Tobin directly owned 22,713 shares of CME Group Class A common stock.
• On September 16, 2024, Tobin acquired 852 shares of CME Group Class A common stock at a price of $218.53.
• After this acquisition, Tobin's direct ownership increased to 23,565 shares of CME Group Class A common stock.

Sentiment

Score: 6

Explanation: Neutral sentiment as it is a standard disclosure of stock transactions. The acquisition of shares could be seen as slightly positive, but it's not a major indicator.

Positives

• The acquisition of 852 shares indicates a potential positive outlook by the reporting person.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. It provides transparency into the executive's holdings and transactions in the company's stock.

Comparison to Industry Standards

• Form 4 filings are standard practice for corporate insiders in publicly traded companies like CME Group, similar to filings made by executives at Intercontinental Exchange (ICE) or Nasdaq, Inc.
• The reporting requirements are governed by Section 16(a) of the Securities Exchange Act of 1934, ensuring transparency in insider trading activities across the financial industry.

Stakeholder Impact

• The transactions may have a minor impact on shareholder sentiment, but are unlikely to significantly affect the company's operations or financial performance.

Key Dates